BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• BioMidwest

  RSNA Release: Hip Steroid Injections Associated With Bone Changes

  The radiologists reported new osteonecrosis in 22-24 percent of hip injection patients, compared to 5-9 percent in the hip control group and 5 percent in the shoulder injection control group.

  November 29, 2017

   · 

  3 min read
• Business

  TM3 Therapeutics Appoints Peter Van Vlasselaer as Chairman of the Board

  Dr. Van Vlasselaer is currently Chief Executive Officer of ARMO Biosciences.

  November 29, 2017

   · 

  4 min read
• Drug Development

  Aldeyra Therapeutics Presents Noninfectious Anterior Uveitis Phase II Clinical Trial Data to the American Uveitis Society Held at the American Academy of Ophthalmology 2017 Annual Meeting

  The results of the analyses demonstrated formal statistical non-inferiority of 0.5% reproxalap ophthalmic solution to Pred Forte.

  November 29, 2017

   · 

  7 min read
• 

  FDA

  FDA Approves Ferring’s CLENPIQ (Sodium Picosulfate, Magnesium Oxide, and Anhydrous Citric Acid) Oral Solution for Colonoscopy Prep

  With availability planned in Q1 2018, CLENPIQ will be the only FDA-approved prescription colonoscopy prep that comes “ready-to-drink”.

  November 29, 2017

   · 

  5 min read
• Revive Therapeutics Announces Successful Final Results of Novel Cannabinoid Delivery Technology Unlocking Commercialization Opportunities in the Medical Cannabis and Pharmaceutical Sectors

  The Company is positioned to advance the development and commercialization of novel medical cannabis products and pharmaceutical cannabinoid therapies internally, with licensed medical cannabis producers, and pharmaceutical companies.

  November 29, 2017

   · 

  7 min read
• Second Sartorius Research Xchange Forum Focuses on Regenerative Medicine and Cell Therapy

  Experts from the biotechnology sector will report on the new developments in cell therapy.

  November 29, 2017

   · 

  1 min read
• Drug Development

  Nippon Chemiphar Announces Progress on Its Hyperuricemia/Gout Projects; NC-2500 Shows Favorable Profile to Lower Serum Uric Acid in Phase-1 Study

  NC-2500 showed favorable urate-lowering properties which may make a difference in gout treatment.

  November 29, 2017

   · 

  2 min read
• 

  Business

  Illumina Opens First Commercial and Customer Training Center in France

  The training center will offer demonstrations, instruction, and education in the latest genomics technologies from Illumina for up to 1,000 scientists a year.

  November 29, 2017

   · 

  4 min read
• BioMidwest

  GE Introduces Healthcare Technology Company to Revolutionize Blood Collection

  Drawbridge Health to simplify the collection and transport of blood samples.

  November 29, 2017

   · 

  4 min read
• Drug Development

  BrainStorm’s Abstracts on Phase II NurOwn Biomarkers Accepted for Presentation at the International Symposium on ALS/MND in Boston

  The posters will feature the analyses of CHIT-1 and microRNAs in the cerebrospinal fluid of ALS patients participating in the Phase II study, as biomarkers to evaluate ALS disease progression and NurOwn treatment response.

  November 29, 2017

   · 

  4 min read